Clinical significance of the expression of estrogen receptors α and β for endocrine therapy of breast cancer

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 52, Issue 1, 2003, Pages

  Iwase, Hirotaka ^a   Zhang, Zhenhan ^a   Omoto, Yoko ^a   Sugiura, Hiroshi ^a   Yamashita, Hiroko ^a   Toyama, Tatsuya ^a   Iwata, Hiroji ^b   Kobayashi, Shunzo ^c  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Nagoya Higashi Municipal Hospital   (Japan)

Author keywords

Estrogen receptor; Hormone responsiveness; Immunohistochemistry; Predictive factor; Progesterone receptor

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GESTAGEN; GONADORELIN DERIVATIVE; PROGESTERONE RECEPTOR; TAMOXIFEN;

BREAST CANCER; CANCER HORMONE THERAPY; CONFERENCE PAPER; CORRELATION COEFFICIENT; ENZYME IMMUNOASSAY; ESTROGEN ACTIVITY; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RNA, NEOPLASM; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 0042326176     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Bast RC, Ravdin P, Hayes DF, Bates S, Fritsche H, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR (2001) 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865
2. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ (2001) Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 19:3817
3. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474
4. Howell A, Dowsett M (1997) Recent advances in endocrine therapy of breast cancer. BMJ 315:863
5. Hu YF, Lau KM, Ho SM, Russo J (1998) Increased expression of estrogen receptor beta in chemically transformed human breast epithelial cells. Int J Oncol 12:1225
6. Iwase H, Itoh Y, Kuzushima T, Yamashita H, Iwata H, Toyama T, Hara Y, Kobayashi S (1997) Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer. Cancer Detect Prev 21:29
7. Jarvinen TA, Pelto-Huikko M, Holli K, Isola J (2000) Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156:29
8. Jensen EV, Cheng G, Palmieri C, Saji S, Makela S, Van Noorden S, Wahlstrom T, Warner M, Coombes RC, Gustafsson JA (2001) Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A 98:15197
9. Kobayashi S, Ito Y, Ando Y, Omoto Y, Toyama T, Iwase H (2000) Comparison of five different antibodies in the immunohistochemical assay of estrogen receptor alpha in human breast cancer. Breast Cancer 7:136
10. Leygue E, Dotzlaw H, Watson PH, Murphy LC (1998) Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res 58:3197
11. Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, Li Y, Younes M (2001) Estrogen receptor beta expression in invasive breast cancer. Hum Pathol 32:113
12. Miyoshi Y, Taguchi T, Gustafsson JA, Noguchi S (2001) Clinicopathological characteristics of estrogen receptor-beta-positive human breast cancers. Jpn J Cancer Res 92:1057
13. Mosselman S, Polman J, Dijkema R (1996) ER-beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49
14. Nomura Y, Kobayashi S, Takatani O, Sugano H, Matsumoto K, McGuire WL (1977) Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients. Cancer Res 37:106
15. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M (1998) Molecular cloning and characterization of human estrogen receptor beta cx: a potential inhibitor of estrogen action in human. Nucleic Acids Res 26:3505
16. Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Kobayashi S, Iwase H (2001) Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett 163:207
17. Omoto Y, Kobayashi S, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Gustafsson JA, Iwase H (2002) Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur J Cancer 38:380
18. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537
19. Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA, Toi M (2002) Expression of estrogen receptor (ER) βcx protein in ERα-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 62:4849
20. Skliris GP, Carder PJ, Lansdown MR, Speirs V (2001) Immunohistochemical detection of ERbeta in breast cancer: towards more detailed receptor profiling? Br J Cancer 84:1095
21. Sonoo H, Kurebayashi J (2000) Predictive factors for response to endocrine therapy in patients with recurrent breast cancer. Breast Cancer 7:297
22. Speirs V, Kerin MJ (2000) Prognostic significance of oestrogen receptor beta in breast cancer. Br J Surg 87:405
23. Toyama T, Iwase H, Watson P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K (1999) Suppression of ING1 expression in sporadic breast cancer. Oncogene 18:5187
24. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R (1998) Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res 58:210